Genfit
Short position disclosed on September 21, 2026.
1.10% of the capital sold short
2 disclosing funds
753 disclosures on record
Evolution of the disclosed total
0%0.5%1%1.5%
Oct 2025Jan 2026Apr 2026Jul 2026
October 13, 2014 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Winton Capital Management Limited | 0.60% | new | September 21, 2026 | |
| Capital Fund Management | 0.50% | new | September 14, 2026 |
On the other side: the funds that hold Genfit Titelia
Get the moves on Genfit by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| September 21, 2026 | Winton Capital Management Limited | 0.60% | still open |
| September 16, 2026 | Winton Capital Management Limited | 0.54% | |
| September 14, 2026 | Capital Fund Management | 0.50% | still open |
| April 28, 2026 | Qube Research & Technologies Limited | 0.47% | April 30, 2026 |
| April 15, 2026 | Qube Research & Technologies Limited | 0.59% | April 30, 2026 |
| April 1, 2026 | Qube Research & Technologies Limited | 0.68% | April 30, 2026 |
| March 25, 2026 | Qube Research & Technologies Limited | 0.78% | April 30, 2026 |
| March 24, 2026 | Qube Research & Technologies Limited | 0.80% | April 30, 2026 |
| March 20, 2026 | Qube Research & Technologies Limited | 0.79% | April 30, 2026 |
| March 19, 2026 | Qube Research & Technologies Limited | 0.80% | April 30, 2026 |
| March 18, 2026 | Qube Research & Technologies Limited | 0.79% | April 30, 2026 |
| March 10, 2026 | Qube Research & Technologies Limited | 0.85% | April 30, 2026 |
| March 5, 2026 | Qube Research & Technologies Limited | 0.90% | April 30, 2026 |
| March 3, 2026 | Qube Research & Technologies Limited | 1.00% | April 30, 2026 |
| February 25, 2026 | Qube Research & Technologies Limited | 1.18% | April 30, 2026 |
| February 24, 2026 | Qube Research & Technologies Limited | 1.21% | April 30, 2026 |
| February 19, 2026 | Qube Research & Technologies Limited | 1.13% | April 30, 2026 |
| February 16, 2026 | Qube Research & Technologies Limited | 1.23% | April 30, 2026 |
| February 12, 2026 | Qube Research & Technologies Limited | 1.12% | April 30, 2026 |
| February 11, 2026 | Qube Research & Technologies Limited | 1.02% | April 30, 2026 |
| February 10, 2026 | Qube Research & Technologies Limited | 0.93% | April 30, 2026 |
| February 9, 2026 | Qube Research & Technologies Limited | 0.89% | April 30, 2026 |
| February 6, 2026 | Qube Research & Technologies Limited | 0.91% | April 30, 2026 |
| February 3, 2026 | Qube Research & Technologies Limited | 0.86% | April 30, 2026 |
| February 2, 2026 | Qube Research & Technologies Limited | 0.90% | April 30, 2026 |
| January 5, 2026 | Qube Research & Technologies Limited | 0.80% | April 30, 2026 |
| December 30, 2025 | GSA Capital Partners LLP | 0.49% | January 2, 2026 |
| December 23, 2025 | Qube Research & Technologies Limited | 0.72% | April 30, 2026 |
| December 22, 2025 | Qube Research & Technologies Limited | 0.68% | April 30, 2026 |
| December 19, 2025 | GSA Capital Partners LLP | 0.50% | January 2, 2026 |
| December 18, 2025 | Qube Research & Technologies Limited | 0.52% | April 30, 2026 |
| December 17, 2025 | GSA Capital Partners LLP | 0.49% | December 19, 2025 |
| November 3, 2025 | GSA Capital Partners LLP | 0.50% | December 19, 2025 |
| October 8, 2025 | Qube Research & Technologies Limited | 0.49% | October 10, 2025 |
| October 3, 2025 | Qube Research & Technologies Limited | 0.53% | October 10, 2025 |
| October 1, 2025 | Qube Research & Technologies Limited | 0.67% | October 10, 2025 |
| September 29, 2025 | Qube Research & Technologies Limited | 0.70% | October 10, 2025 |
| September 24, 2025 | Qube Research & Technologies Limited | 0.64% | October 10, 2025 |
| September 22, 2025 | Qube Research & Technologies Limited | 0.55% | October 10, 2025 |
| March 10, 2025 | Worldquant, LLC | 0.49% | March 12, 2025 |
| March 4, 2025 | Worldquant, LLC | 0.52% | March 12, 2025 |
| July 8, 2024 | Arrowstreet Capital, Limited Partnership | 0.46% | July 10, 2024 |
| June 28, 2024 | Arrowstreet Capital, Limited Partnership | 0.57% | July 10, 2024 |
| April 5, 2024 | Arrowstreet Capital, Limited Partnership | 0.69% | July 10, 2024 |
| March 1, 2024 | Arrowstreet Capital, Limited Partnership | 0.72% | July 10, 2024 |
| January 9, 2024 | Arrowstreet Capital, Limited Partnership | 0.69% | July 10, 2024 |
| November 9, 2023 | Arrowstreet Capital, Limited Partnership | 0.71% | July 10, 2024 |
| October 20, 2023 | Arrowstreet Capital, Limited Partnership | 0.64% | July 10, 2024 |
| October 13, 2023 | Arrowstreet Capital, Limited Partnership | 0.50% | July 10, 2024 |
| August 18, 2021 | Citadel Europe LLP | 0.47% | August 20, 2021 |
Download 753 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Ubisoft Entertainment 12.49% of the capital sold short
- Valeo 11.40% of the capital sold short
- Renault 9.16% of the capital sold short
- Viridien 8.08% of the capital sold short
- Teleperformance 7.58% of the capital sold short
- FDJ United 6.19% of the capital sold short
- Abivax 5.10% of the capital sold short
- Elis 4.91% of the capital sold short
- Alstom 4.57% of the capital sold short
- Rémy Cointreau 4.46% of the capital sold short
- Sopra Steria Group 3.92% of the capital sold short
- Spie SA 3.75% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Genfit, source AMF, data as at September 21, 2026, https://www.quivad.com/action/genfit